THE METHOD OF TREATMENT OF PATIENTS WITH LOCALLY-ADVANCED BREAST CANCER-Reference-Cited by-同舟云学术

THE METHOD OF TREATMENT OF PATIENTS WITH LOCALLY-ADVANCED BREAST CANCER

Published:2016-01-29 Issue: Volume:1 Page:45-50
ISSN:2504-5679
Container-title:EUREKA: Health Sciences
language:en
Short-container-title:

Author:

Sedakov Igor¹,Dubinina Vladlena²,Bondar Oleksandr³,Lukianchuk Oleg⁴

Affiliation:

1. Donetsk Regional Antitumoral Center

2. Odessa Medical University

3. Odessa University Clinic

4. Cancer hospital

Abstract

A method of care of patients with locally-advanced breast cancer consisting of using regional selective intraarterial chemotherapy in the schedule of the complex (palliative) treatment is presented. Results of treatment showed an advantage in comparison with the application of traditional methods of the breast cancer treatment. The methodology on intra-arterial introduction of chemotherapeutic agents developed at Donetsk Regional Antitumoral Center and University clinic of Odessa showed its undisputable contribution into development of modern oncology through decrease of primary tumoral locus, transition from inoperable state into the state at which it is possible to perform the radical volume of surgical interference to patient. The special attention is paid to development of new methods of treating BC patients (regional forms of disease) with unfavorable factors for forecast of tumor growth.

Publisher

OU Scientific Route

Reference22 articles.

1. Aksel, E. M. (2006). Malignant neoplasm of the breast: state of oncologic care, morbidity and mortality. Mammalogy, 1, 9–13.

2. Shalіmova, S. O. (Ed.) (2012). Cancer in Ukraine. Morbidity, indices of activity of the oncologic service. Bulletin of the national Cancer register of Ukraine. Kiev, 13, 51.

3. Bondar, G. V., Sedakov, І. E., Shlopov, V. G. (2006). Primary breast cancer. Donetsk: Kashtan, 348.

4. Tsunoda, Y., Suzuki, K., Sakamoto, M. A. et. al (2009). Evaluation of fluorouracil-related genes in breast cancer to predict the effect of adjuvant therapy with CMF. Gan To Kagaku Ryoho., 36 (1), 51–55.

5. Chen, A. M., Meric-Bernstam, F., Hunt, K. K. et. al (2004). Conservation After Neoadjuvant Chemotherapy: The M.D. Anderson Cancer Center Experience. Journal of Clinical Oncology, 22, 2303–2312.